Advertisement

Topics

Tenax Therapeutics, Inc. Company Profile

18:55 EDT 22nd June 2018 | BioPortfolio

Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The company owns the North American rights to develop and commercialize levosimendan, and the United States Food and Drug Administration (FDA) has granted Fast Track status for levosimendan for the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome (LCOS). The company initiated a Phase 3 trial with levosimendan in that indication in July 2014. For more information, visit www.tenaxthera.com.


News Articles [801 Associated News Articles listed on BioPortfolio]

FDA OKs Tenax's midstage protocol for pulmonary hypertension candidate

The FDA said the midstage clinical protocol for Tenax Therapeutics' levosimendan, which is indicated to treat patients with p -More- 

Tenax Therapeutics Announces New Scientific Publication of Preclinical Data Provides Additional ...

Read more...

Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, today announ...

TENX Heartened After Meeting With FDA, RXII To Report Data In May, GALT On Watch

Tenax Therapeutics gained over 47% on Wednesday after it announced that it had a productive pre-Investigational New Drug (pre-IND) meeting with the FDA for a phase II study of Levosimendan in Pulmonar...

TENX Heartened, AXGN Sees 40% Revenue Growth, Mark Your Calendar For REPH

Tenax Therapeutics Inc. gained 128.45% on Thursday, following promising results of a preclinical study of Levosimendan, published in the journal named Pulmonary Circulation. The results suggest that c...

Tenax Therapeutics Announces Results of Pre-IND Meeting with FDA for Phase 2 Study of Levosimendan in PH-HFpEF Patients

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, today announ...

Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies

Phase 2 Trial will investigate Levosimendan in Pulmonary Hypertension-WHO Group 2 patients with preserved ejection fraction (PH-HFpEF) Tenax Therapeutics, Inc. (NASDAQ...

Your Daily Pharma Scoop: Tenax Surges, Eli Lilly's CYRAMZA, Cellectics Public Offering

PubMed Articles [441 Associated PubMed Articles listed on BioPortfolio]

EFFECTS OF TYPE AND QUANTITY OF ORGANIC CARBON ON THE BIOACCESSIBILITY OF POLYCHLORINATED BIPHENYLS IN CONTAMINATED SEDIMENTS.

Organic carbon (OC) principally controls sorption and desorption of hydrophobic organic compounds in sediments. We investigated the effects of OC type and quantity on compound bioaccessibility. The de...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [145 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1239 Associated Companies listed on BioPortfolio]

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical...

Tenax Implant Inc.

Nil

Tenax Implants

Dental Implants

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Tenax Therapeutics, Inc." on BioPortfolio

We have published hundreds of Tenax Therapeutics, Inc. news stories on BioPortfolio along with dozens of Tenax Therapeutics, Inc. Clinical Trials and PubMed Articles about Tenax Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tenax Therapeutics, Inc. Companies in our database. You can also find out about relevant Tenax Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record